Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Launched by HELIO GENOMICS · Jan 5, 2022

Keywords

ClinConnect Summary

This clinical trial is looking to collect blood samples from different groups of people, including healthy individuals, those with benign (non-cancerous) conditions, and patients with various types of cancer. The main goal is to study specific DNA markers in the blood that can help detect cancer and to understand how certain benign conditions or treatments, like chemotherapy, might affect the accuracy of these tests. This research is important because it could lead to better ways to diagnose cancer and improve patient care.

To participate, you need to be at least 18 years old and either have a diagnosis of cancer or a benign condition like liver cirrhosis, diabetes, or chronic hepatitis, or be a healthy volunteer. Participants will be asked to provide about 50 milliliters of blood over an 8-week period. If you've already donated blood in that time, you won’t be able to participate. If you're interested, please be aware that you'll need to sign a consent form to take part in this study. Your involvement could help advance our understanding of cancer detection and treatment.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 2.1.1 Age 18 years or older.
• • 2.1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
• Exclusion Criteria:
• • 2.2.1 Patients that are unwilling or unable to sign the Informed Consent Form will be excluded.
• • 2.2.2 Approximately 50 mL of blood will be drawn from participants within an 8-week period under this protocol. Patients that have already given 50 mL of blood within this time frame will be excluded.